Log in
Enquire now
Evommune

Evommune

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2C
B2C
CEO
‌
Luis Pena
Legal Name
Evommune, Inc.
0
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...evommune
Founder
‌
Hans Hofland
‌
Luis Pena
Industry
Pharmaceutical industry
Pharmaceutical industry
Healthcare
Healthcare
Biotechnology
Biotechnology
Investors
EQT Life Sciences
EQT Life Sciences
Pivotal bioVenture Partners
Pivotal bioVenture Partners
‌
LSP BioVentures
0
Marshall Wace
Marshall Wace
Longwood Fund
Longwood Fund
Sectoral Asset Management
Sectoral Asset Management
RA Capital Management
RA Capital Management
RTW Investments LLC
RTW Investments LLC
‌
NEXTBio Capital
Andera Partners
Andera Partners
Latest Funding Round Date
October 31, 2024
Latest Funding Round Amount (USD)
115,000,000
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/evommune
Location
Palo Alto, California
Palo Alto, California
Number of Employees (Ranges)
11 – 50
Pitchbook URL
pitchbook.com/profiles...453499-48
Total Funding Amount (USD)
198,000,000
Official Website
evommune.com

Find more companies like Evommune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.